Back to 
WELLS FARGO & COMPANY/MN
WELLS FARGO & COMPANY/MN
SCTLShowing 0 of 20 quarters
Position history for WELLS FARGO & COMPANY/MN's holdings in RECRO PHARMA INC
No. Wells Fargo exited its SCTL (Recro Pharma) position in Q2 2024. Its Q1 2024 13F listed 954 shares worth $1,030. Wells Fargo already held SCTL in its Q3 2019 13F, the earliest on record, and held it in 19 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of SCTL: RENAISSANCE TECHNOLOGIES LLC, PANAGORA ASSET MANAGEMENT INC, MILLENNIUM MANAGEMENT LLC